Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a 403 Forbidden message and minimal navigation, removing access to the full study record details and related resources.SummaryDifference17%

- Check20 days agoChange DetectedThe page shows Revision: v3.7.0 replacing Revision: v3.6.6. This represents a system or UI update, not changes to the study text.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, signaling a minor patch or update to the page or its underlying tooling. This update does not change the study details or visible content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe 'Other Study ID Numbers' section now includes '2015 ( U.S. NIH Grant/Contract )', indicating NIH funding for the study. This addition provides context about the funding source associated with the trial.SummaryDifference0.0%

- Check55 days agoChange DetectedThe revision history now shows a new version v3.6.5, replacing v3.6.4. This reflects an update to the page's documentation/versioning rather than substantive content changes.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page's revision tag was updated to v3.6.4, replacing the previous v3.6.3 as part of an internal revision history update.SummaryDifference0.0%

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.